sofosbuvir has been researched along with Multiple Myeloma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barwick, BG; Boise, LH; Cheng, X; Hashimoto, H; Lonial, S; Vertino, PM; Wang, D; Zhang, X | 1 |
Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA | 1 |
2 other study(ies) available for sofosbuvir and Multiple Myeloma
Article | Year |
---|---|
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma.
Topics: Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; CpG Islands; Cytosine; DNA; E-Box Elements; Epigenesis, Genetic; Multiple Myeloma; Mutation; Protein Binding; Protein Conformation; Repressor Proteins | 2017 |
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Head and Neck Neoplasms; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferons; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasms; Polyethylene Glycols; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |